Aveanna Healthcare Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Aveanna Healthcare Hldgs (AVAH).

Price Target Range — 9 Quarters

Analyst Consensus — 11 Analysts

1S.Buy

7Buy

3Hold

Consensus RatingNeutral# Analysts11Avg. Consensus PT$13Upside to Avg. PT+5.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	JP Morgan	Benjamin Rossi	PT Raise	Neutral	$8→$15
Aug 28, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$10→$15
Aug 24, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$11→$15
Aug 24, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$10→$16
Aug 14, 2026	UBS	A.J. Rice	PT Raise	Neutral	$8→$13
Aug 14, 2026	Raymond James	John Ransom	PT Raise	Strong Buy	$13→$15
Aug 14, 2026	BMO Capital	Sean Dodge	PT Raise	Outperform	$10→$14
Jul 14, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$9→$11
Jul 9, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$9→$10
Jun 3, 2026	RBC Capital	Ben Hendrix	Upgrade	Sector Perform→Outperform	$10
May 20, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$8→$9
May 18, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$10→$9
May 15, 2026	Stephens & Co.	Scott Fidel	Upgrade	Equal-Weight→Overweight	$10→$11
May 15, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$9→$10
Apr 13, 2026	Truist Securities	David Macdonald	PT Cut	Hold	$9→$8
Mar 25, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$11→$10
Mar 23, 2026	RBC Capital	Ben Hendrix	PT Cut	Sector Perform	$11→$9
Mar 20, 2026	BMO Capital	Sean Dodge	PT Cut	Outperform	$11→$10
Mar 20, 2026	Truist Securities	David Macdonald	PT Cut	Hold	$10→$9
Jan 16, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$9→$11

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $11 to $15.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and raises the price target from $10 to $16.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $13.

Benzinga Newsdesk

PRO
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15

Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong Buy and raises the price target from $13 to $15.

Benzinga Newsdesk

Aveanna Healthcare Holdings Inc

Aveanna Healthcare Hldgs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

PRO
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

PRO
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15

People Also Watch

People Also Watch

Aveanna Healthcare Holdings Inc

Aveanna Healthcare Hldgs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

PROBarclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

PROTruist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRORBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

PROUBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

PRORaymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

PRO
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

PRO
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15